LG SIGNATURE LSR100 Manuel Du Propriétaire page 48

Contaminant Average
Reduction Influent
100,000
Cyst*
cysts/L
Atenolol 240 ng/L
Carbamazepine 1600 ng/L
DEET 1600 ng/L
Trimethoprim 170 ng/L
Linuron 160 ng/L
Phenytoin 200 ng/L
Ibuprofen 400 ng/L
Naproxen 140 ng/L
Estrone 120 ng/L
Bisphenol A 2000 ng/L
Nonyl Phenol 1600 ng/L
• Based on the use of Cryptosporidium parvum oocysts.
48
NSF specified
Avg %
Challenge
Reduction
Concentration
Minimum
>99.99%
50,000 cysts/L
200 ± 40%
> 95.50% 10.80 ng/L
ng/L
1400 ± 40%
0.984
ng/L
1400 ± 40%
0.971
ng/L
140 ± 40%
>96.80%
ng/L
140 ± 40%
>96.60%
ng/L
200 ± 40%
>94.80%
ng/L
400 ± 40%
>94.50%
ng/L
140 ± 40%
>96.10%
ng/L
140 ± 40%
>96.10%
ng/L
2000 ± 40%
>98.90%
ng/L
1400 ± 40%
>97.10%
ng/L
Max
Average
Permissible
Product Water
Product Water
Concentration
Concentration
10 N/A
30 ng/L
25.60 ng/L 200 ng/L
46.40 ng/L 200 ng/L
5.44 ng/L 20 ng/L
5.44 ng/L 20 ng/L
10.40 ng/L 30 ng/L
22.00 ng/L 60 ng/L
5.46 ng/L 20 ng/L
4.68 ng/L 20 ng/L
22.00 ng/L 300 ng/L
46.40 ng/L 200 ng/L
EN
NSF
Reduction
equirements
≥ 99.95%
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA